RenovoRx Inc. (RNXT)
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment
Other Report or Announcement
NeoVolta Receives $1.9 Million First Purchase Order from Luminia, Accelerating Commercial and Industrial Energy Storage Platform
Better and Coinbase Launch the First Token-Backed, Conforming Mortgage
KULR ONE Battery Architecture Enters Electric Aviation: KULR Technology Group Signs Agreement with Robinson Helicopter as Battery Co-Developer for eR66 Electric Helicopter Demonstrator
Duos Technologies Group Sets Fourth Quarter and Full Year 2025 Earnings Call for Tuesday, March 31, 2026 at 4:30 PM ET
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisiniclines Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System